HemOncToday.com RSS Daily Feedhttp://www.HemOncToday.com/rssDisplay.aspxen-us03/11/2010The latest news and articles from the Endocrinology Today, leading publication on the web.Copyright 2008 HemOnc Today. All Rights Reserved.5CD68+ cells associated with primary treatment failure, poor survival in Hodgkin’s lymphomahttp://www.HemOncToday.com/article.aspx?rid=61844Thu, 11 Mar 2010 13:26:00 GMTCD68+ cells associated with primary treatment failure, poor survival in Hodgkin’s lymphomahttp://www.HemOncToday.com/article.aspx?rid=61844Thu, 11 Mar 2010 13:26:00 GMTBoxed warning added to WinRhohttp://www.HemOncToday.com/article.aspx?rid=61805Thu, 11 Mar 2010 10:58:00 GMTGene expression levels influenced prostate cancer outcomeshttp://www.HemOncToday.com/article.aspx?rid=61793Thu, 11 Mar 2010 09:29:00 GMTGene expression levels influenced prostate cancer outcomeshttp://www.HemOncToday.com/article.aspx?rid=61793Thu, 11 Mar 2010 09:29:00 GMTRecommendations issued to reduce incidence of VTEhttp://www.HemOncToday.com/article.aspx?rid=61773Wed, 10 Mar 2010 14:40:00 GMTRecommendations issued to reduce incidence of VTEhttp://www.HemOncToday.com/article.aspx?rid=61773Wed, 10 Mar 2010 14:40:00 GMTNew oral anticoagulants may replace warfarinWith some agents already approved in Europe and Canada, the long-awaited move away from warfarin may be starting.http://www.HemOncToday.com/article.aspx?rid=61744Wed, 10 Mar 2010 12:10:00 GMTWarfarin use increased risk for brain bleed after IV tissue plasminogen activator usehttp://www.HemOncToday.com/article.aspx?rid=61762Wed, 10 Mar 2010 10:39:00 GMTWarfarin use increased risk for brain bleed after IV tissue plasminogen activator usehttp://www.HemOncToday.com/article.aspx?rid=61762Wed, 10 Mar 2010 10:39:00 GMT